BeStock  
Stocks › Biotechnology › CYTK

Cytokinetics CYTK

US equityMarket cap rank #1720Biotechnology
$50.78 −$0.68 (-1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $52.48 +3.35%
Open$51.27
Prev close$51.46
Day range$50.60 – $53.45
Volume1.43M
Market cap$7.07B
P/E (TTM)–
Dividend yield–

CYTK Stock News

Headlines matching Cytokinetics or the CYTK ticker, most recent first.

  • Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112Market news · 2 Sep 2026 · Direct mention
  • Cytokinetics(CYTK.US) Officer Sells US$7.34 Million in Common StockMarket news · 16 Sep 2026 · Direct mention
  • Form 144 | Cytokinetics(CYTK.US) Insider Proposes to Sell 7.09 Million in Common StocksMarket news · 16 Sep 2026 · Direct mention
  • Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)TipRanks · 10 Sep 2026 · Direct mention
  • RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112Market news · 10 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $85 to $140Market news · 1 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140Market news · 8 Aug 2026 · Direct mention
  • BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $85Market news · 31 Aug 2026 · Direct mention
  • Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $110Market news · 27 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy RatingMarket news · 20 Aug 2026 · Direct mention
  • Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $110 PositiveMarket news · 14 Aug 2026 · Direct mention
  • Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $112Market news · 13 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103Market news · 13 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $103 PositiveMarket news · 13 Aug 2026 · Direct mention
  • Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $102Market news · 31 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CYTK.

Sign in to join the discussion.

Scroll to Top